New diagnostic index for prediction of severe irAEs in patients with metastatic melanoma taking checkpoint inhibitors.

被引：0
|
作者：
Zhukova, Natalia V.
Orlova, Rashida
Malkova, Anna
Kaledina, Ekaterina
Demchenkova, Alexandra
Naymushina, Polina
Nazarov, V.
Mazing, A.
Lapin, S.
Beliak, Natalia P.
Shoenfeld, Y.
机构：
[1] St Petersburg State Univ, Fac Med, St Petersburg, Russia
[2] St Petersburg State Univ, St Petersburg, Russia
[3] SPb SBIH, City Clin Oncol Dispensary, St Petersburg, Russia
[4] Pavlov First St Petersburg State Med Univ, St Petersburg, Russia
[5] Ariel Univ, Ariel, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21565
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The Novel Diagnostic Index Based on HLA-DRB1 Genotype and PD-L1 Expression can Predict Severe irAEs in Patients with Metastatic Melanoma Taking Immune Checkpoint Inhibitors. The Results of the Pilot Study
    Zhukova, N.
    Orlova, R.
    Malkova, A.
    Kaledina, E.
    Demchenkova, A.
    Naimushina, P.
    Nazarov, V.
    Mazing, A.
    Lapin, S.
    Belyak, N.
    Shoenfeld, Y.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2022, 42 (03) : 1 - 9
  • [2] Relationship between IL-1β and IL-8 serum concentrations in patients with metastatic melanoma taking checkpoint inhibitors.
    Orlova, Rashida
    Malkova, Anna
    Zhukova, Natalia V.
    Kaledina, Ekaterina
    Demchenkova, Alexandra
    Naymushina, Polina
    Sharoyko, Vladimir
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Immune profiling of metastatic uveal melanoma and response to immune checkpoint inhibitors.
    Shao, Yusra F.
    Baca, Yasmine
    Xiu, Joanne
    Vanderwalde, Ari M.
    In, Gino Kim
    Hoon, Dave S. B.
    Domingo-Musibay, Evidio
    Darabi, Sourat
    Eisenberg, Burton Larry
    Sato, Takami
    Gibney, Geoffrey Thomas
    Mamdani, Hirva
    Moser, Justin C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Toxicity, response, and survival in older adults with metastatic melanoma treated with checkpoint inhibitors.
    De Glas, Nienke A.
    Bastiaannet, Esther
    Van den Bos, Frederiek
    Mooijaart, Simon
    Van der Veldt, Astrid Aplonia Maria
    Suijkerbuijk, Karijn
    Aarts, Maureen J. B.
    Van den Berkmortel, Franchette
    Blank, Christian U.
    Boers-Sonderen, Marye
    Van den Eertwegh, Alfonsus Johannes Maria
    de Groot, Jan Willem
    Hospers, Geke
    Haanen, John B. A. G.
    Piersma, Djura
    Van Rijn, Rozemarijn
    Ten Tije, A. J.
    Wouters, Michel W. J. M.
    Portielje, Johanna Elisabeth A.
    Kapiteijn, Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Long-term symptom burden and quality of life in metastatic melanoma patients treated with checkpoint inhibitors.
    Mamoor, Maha
    Lavery, Jessica A.
    Sidlow, Robert
    Rogak, Lauren J.
    Thom, Bridgette
    Khan, Niloufer
    Baxi, Shrujal S.
    Wolchok, Jedd D.
    Postow, Michael A.
    Korenstein, Deborah
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Comparing overall survival of patients with metastatic uveal melanoma by sequence of Tebentafusp versus combination immune checkpoint inhibitors.
    Shikdar, Sufana
    Day, Silas
    Ikeguchi, Alexandra
    Ying, Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Immune Prognostic Index as a predictor of survival in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Stukalin, Igor
    Suo, Aleksi
    Vallerand, Isabelle A.
    Lewinson, Ryan
    Heng, Daniel Y. C.
    Bebb, D. Gwyn
    Morris, Don G.
    Cheng, Tina
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB100 - AB100
  • [8] PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors
    Gabrys, H. S.
    Basler, L.
    Burgermeister, S.
    Hogan, S.
    Ahmadsei, M.
    Pavic, M.
    Bogowicz, M.
    Vuong, D.
    Tanadini-Lang, S.
    Foerster, R.
    Kudura, K.
    Huellner, M.
    Dummer, R.
    Levesque, M. P.
    Guckenberger, M.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Surgery in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Janssen, Josephine C.
    Huibers, Anne E.
    Grunhagen, Dirk J.
    Bagge, Roger Olofsson
    SCANDINAVIAN JOURNAL OF SURGERY, 2025,
  • [10] Hyperprogressive disease in patients with metastatic genitourinary tumors treated with immune checkpoint inhibitors.
    Suarez, Cristina
    Morales-Barrera, Rafael
    Garcia-Ruiz, Alonso
    Gonzalez, Macarena
    Ligero, Marta
    Valverde, Claudia
    Serrano, Cesar
    Mateo, Joaquin
    Perez-Lopez, Raquel
    Carles, Joan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345